Novel oral, broad-spectrum matrix metalloproteinase inhibitor (MMPI), being >10-fold more active than marimastat in inhibiting the processing of cell-bound TNF-alpha

Novel long-acting, reversible albumin-binding growth hormone (GH) derivative for treatment of growth hormone dificiency

Unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reducing GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours.

Novel potent and selective allosteric modulator of sigma-1 receptor

Novel, selective and orally bioavailable c-Met inhibitor, exhibiting antitumor activity both in vitro and in vivo

A2A adenosine receptor agonist

Natural analgesic, antipyretic, anti-inflammatory, and anti-tumor agent

Inhibitor of constitutive and inducible STAT3 activation through the activation of SHP-2 tyrosine phosphatase

Natural inhibitor of the Kv1.3 channels in a concentration-dependent manner

Human norepinephrine transporter blocker

DAT modulator, being unique in affecting substrate uptake without impacting efflux

Novel partial inhibitor of amphetamine-induced dopamine release

Sorting inhibitor, blocking Vps16 function, one protein in the class C tethering complex, and increasing aflatoxin synthesis and export

Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1)

Novel telomerase inhibitor

0

Novel photo-controllable hydrogen sulfide donor applicable in live cells

Novel anti-tuberculosis agent against intracellular Mycobacterium tuberculosis

Antibiotic, binding to the bacterial 30S ribosomal subunit, interfering with the initiation of protein synthesis and with proper protein elongation and leading to bacterial cell death

Novel gamma-secretase modulator

Novel selective orally bioavailable inhibitor of p300/CBP histone acetyltransferase

Novel p53 Stabilizer for Brain Cell Differentiation